SEC CIK 1610384
Luthringer Remy
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| NERVview stock → | 68,994 | 2023-05-02 |
Position History — NERV
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — NERV
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-03 | Grant / award (derivative) | 1,690,700 | $0.00 | 1,690,700 |
| 2025-12-22 | Grant / award (derivative) | 2,250,000 | $0.00 | 2,250,000 |
| 2024-12-05 | Grant / award (derivative) | 105,000 | $0.00 | 105,000 |
| 2023-10-04 | Grant / award (derivative) | 100,450 | $0.00 | 100,450 |
| 2023-05-02 | Open-market sale | 3,641 | $3.76 | 68,994 |
| 2023-05-01 | Open-market sale | 23,753 | $3.85 | 72,635 |
| 2023-04-28 | Grant / award | 88,077 | $0.00 | 96,388 |
| 2022-12-13 | Grant / award (derivative) | 45,000 | $0.00 | 45,000 |
| 2022-02-16 | Grant / award (derivative) | 505,000 | $0.00 | 505,000 |
| 2020-12-16 | Open-market sale | 1,300 | $2.64 | 66,490 |
| 2020-12-14 | Option exercise (derivative) | 18,750 | $0.00 | 0 |
| 2020-12-14 | Option exercise | 18,750 | — | 67,790 |
| 2020-10-13 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2020-06-19 | Grant / award (derivative) | 354,302 | $0.00 | 354,302 |
| 2019-12-31 | Grant / award (derivative) | 95,698 | $0.00 | 95,698 |
| 2019-12-17 | Open-market sale | 2,412 | $7.10 | 49,040 |
| 2019-12-14 | Option exercise (derivative) | 18,750 | $0.00 | 18,750 |
| 2019-12-14 | Option exercise | 18,750 | — | 51,452 |
| 2018-12-17 | Open-market sale | 2,604 | $7.46 | 32,702 |
| 2018-12-14 | Option exercise (derivative) | 18,750 | $0.00 | 37,500 |
| 2018-12-14 | Option exercise | 18,750 | — | 35,306 |
| 2018-12-11 | Grant / award (derivative) | 410,000 | $0.00 | 410,000 |
| 2018-01-02 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2017-12-14 | Option exercise (derivative) | 18,750 | $0.00 | 56,250 |
| 2017-12-14 | Option exercise | 18,750 | — | 18,750 |
| 2017-12-14 | Open-market sale | 2,194 | $5.85 | 16,556 |
| 2017-12-13 | Grant / award (derivative) | 350,000 | $0.00 | 350,000 |
| 2017-02-06 | Option exercise (derivative) | 2,185 | $0.00 | 285,719 |
| 2017-02-06 | Option exercise | 2,185 | $4.71 | 2,185 |
| 2017-02-06 | Open-market sale | 2,185 | $11.00 | 0 |
| 2017-02-03 | Option exercise (derivative) | 32,096 | $0.00 | 287,904 |
| 2017-02-03 | Option exercise | 32,096 | $4.71 | 32,096 |
| 2017-02-03 | Open-market sale | 32,096 | $11.02 | 0 |
| 2016-12-14 | Grant / award (derivative) | 150,000 | $0.00 | 150,000 |
| 2016-12-14 | Grant / award (derivative) | 75,000 | $0.00 | 75,000 |
| 2015-12-04 | Grant / award (derivative) | 320,000 | $0.00 | 320,000 |
| 2015-04-14 | Grant / award (derivative) | 399,623 | $0.00 | 399,623 |
| 2014-06-30 | — | — | — | 926,604 |
| 2014-06-30 | Grant / award (derivative) | 441,973 | $0.00 | 441,973 |
| 2014-06-30 | Grant / award (derivative) | 207,869 | $0.00 | 649,842 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.